Glivec/Gleevec Pediatric (Age 1 to Less Than 4) PK Study in CML, Ph+ ALL Patients and Other Glivec/Gleevec® Indicated Hematological Disorders.

NCT01066468 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

3

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Myeloid Leukemia (CML)
Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
Other Glivec/Gleevec Indicated Hematological Disorders (HES, CEL, MDS/ MPN)

Interventions

DRUG: Gleevec/Glivec

Sponsor

Novartis Pharmaceuticals